![]() | |
Names | |
---|---|
Preferred IUPAC name
N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide | |
Other names
Rafoxanid, raphoxanide
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.041.029 |
EC Number |
|
KEGG | |
MeSH | D011888 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H11Cl2I2NO3 | |
Molar mass | 626.01 g/mol |
Appearance | Slight yellowish-brown injectable solution and white oral solution |
In oily solutes | |
Pharmacology | |
QP52AG05 (WHO) | |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Has low safety index (6 times as normal dose) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Rafoxanide is a salicylanilide used as an anthelmintic.[1] It is most commonly used in ruminant animals to treat adult liver flukes of the species Fasciola hepatica and Fasciola gigantica.[1]
References
- ^ a b Lanusse, Carlos E.; Alvarez, Luis I.; Virkel, Guillermo L. (2018). "Chapter 40. Anticestodal and antitrematodal drugs. Rafoxanide". In Riviere, Jim E.; Papich, Mark G. (eds.). Veterinary Pharmacology and Therapeutics (10th ed.). John Wiley & Sons. p. 1091. ISBN 9781118855829.